Completed PHASE2 INTERVENTIONAL 2-arm NCT04919317

Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty

Enhanced Pain Control After Reduction Mammaplasty With Bupivicaine and Dexamethasone Regional Block: a Double-blind Randomized Controlled Trial

Sponsor: Temple University

Conditions Mammaplasty Pain, Postoperative

Interventions Dexamethasone 4mg Saline

Updated 5 times since 2021 Last updated: Oct 8, 2023 Started: Sep 29, 2017 Primary completion: Nov 7, 2020 Completion: Nov 25, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Mammaplasty and Pain, Postoperative, this trial is completed. The trial is conducted by Temple University and has accumulated 5 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Nov 2023 — Jul 2024 [monthly]

Completed PHASE2
Sep 2022 — Nov 2023 [monthly]

Completed PHASE2
Sep 2021 — Sep 2022 [monthly]

Completed PHASE2

First recorded

Sep 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Temple University

Data source: Temple University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Philadelphia, United States